Literature DB >> 23508679

Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.

Mehmet Firat Mutlu1, Mehmet Erdem, Ahmet Erdem, Sule Yildiz, Ilknur Mutlu, Ozgur Arisoy, Mesut Oktem.   

Abstract

PURPOSE: To determine the predictive value of serum anti-müllerian hormone (AMH) concentrations and antral follicle counts (AFC), on ovarian response and live birth rates after IVF and compare with age and basal FSH.
METHODS: Basal levels of AMH, FSH and antral follicle count were measured in 192 patients prior to IVF treatment. The predictive value of these parameters were evaluated in terms of retrieved oocyte number and live birth rates.
RESULTS: Poor responders in IVF were older, had lower AFC and AMH but higher basal FSH levels. In multivariate analysis AFC was the best and only independent parameter among other parameters and AMH was better than age and basal FSH to predict poor response to ovarian stimulation. Addition of AMH, basal FSH, age and total gonadotropin dose to AFC did not improve its prognostic reliability. Area under curve (AUC) for each parameter according to ROC analysis also revealed that AFC performed better in poor response prediction compared with AMH, basal FSH and age. The cut-off point for mean AMH and AFC in discriminating the best between poor and normal ovarian response cycles was 0.94 ng/mL (with a sensitivity of 70% and a specificity of 86%) and 5.5 (with a sensitivity of 91% and a specificity of 91%), respectively. However, age was the only independent predictor of live birth in IVF as compared to hormonal and ultrasound indices of ovarian reserve.
CONCLUSION: AFC is better than AMH to predict poor ovarian response. Although AMH and AFC could be used to predict ovarian response they had limited value in live birth prediction. The only significant predictor of the probability of achieving a live birth was age.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23508679      PMCID: PMC3663963          DOI: 10.1007/s10815-013-9975-3

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  64 in total

Review 1.  Ovarian reserve testing and the use of prognostic models in patients with subfertility.

Authors:  A Bukman; M J Heineman
Journal:  Hum Reprod Update       Date:  2001 Nov-Dec       Impact factor: 15.610

2.  Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.

Authors:  Peter Y K Yong; David T Baird; K Joo Thong; Alan S McNeilly; Richard A Anderson
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

3.  Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

Authors:  Jesper M J Smeenk; Fred C G J Sweep; Gerhard A Zielhuis; Jan A M Kremer; Chris M G Thomas; Didi D M Braat
Journal:  Fertil Steril       Date:  2006-11-01       Impact factor: 7.329

4.  Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?

Authors:  R Nahum; J L Shifren; Y Chang; L Leykin; K Isaacson; T L Toth
Journal:  J Assist Reprod Genet       Date:  2001-03       Impact factor: 3.412

5.  Early follicular antimüllerian hormone as an indicator of ovarian reserve.

Authors:  Cem Fiçicioglu; Tayfun Kutlu; Elif Baglam; Zeynep Bakacak
Journal:  Fertil Steril       Date:  2006-03       Impact factor: 7.329

6.  Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility.

Authors:  G J Scheffer; F J Broekmans; M Dorland; J D Habbema; C W Looman; E R te Velde
Journal:  Fertil Steril       Date:  1999-11       Impact factor: 7.329

7.  Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

Authors:  D B Seifer; G Lambert-Messerlian; J W Hogan; A C Gardiner; A S Blazar; C A Berk
Journal:  Fertil Steril       Date:  1997-01       Impact factor: 7.329

8.  The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization.

Authors:  Ellen R Klinkert; Frank J M Broekmans; Caspar W N Looman; J Dik F Habbema; Egbert R te Velde
Journal:  Fertil Steril       Date:  2005-03       Impact factor: 7.329

9.  Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

Authors:  A La Marca; S Giulini; A Tirelli; E Bertucci; T Marsella; S Xella; A Volpe
Journal:  Hum Reprod       Date:  2006-10-27       Impact factor: 6.918

Review 10.  Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

Authors:  A La Marca; G Sighinolfi; D Radi; C Argento; E Baraldi; A Carducci Artenisio; G Stabile; A Volpe
Journal:  Hum Reprod Update       Date:  2009-09-30       Impact factor: 15.610

View more
  25 in total

1.  The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI: a meta-analysis.

Authors:  Lingnv Yao; Wei Zhang; Hong Li; Wenqin Lin
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Serum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization.

Authors:  Carolina P Rezende; Ana L Rocha; Cynthia Dela Cruz; Lavinia E Borges; Helen L Del Puerto; Fernando M Reis
Journal:  J Assist Reprod Genet       Date:  2014-07-12       Impact factor: 3.412

Review 3.  Anti-müllerian hormone as a predictor for live birth among women undergoing IVF/ICSI in different age groups: an update of systematic review and meta-analysis.

Authors:  Ni-Jie Li; Qing-Yun Yao; Xiao-Qiong Yuan; Yong Huang; Yu-Feng Li
Journal:  Arch Gynecol Obstet       Date:  2022-07-30       Impact factor: 2.493

4.  The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF.

Authors:  L Kotanidis; K Nikolettos; S Petousis; B Asimakopoulos; E Chatzimitrou; G Kolios; N Nikolettos
Journal:  J Endocrinol Invest       Date:  2016-07-27       Impact factor: 4.256

5.  The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments.

Authors:  Irene Souter; Kristen W Smith; Irene Dimitriadis; Shelley Ehrlich; Paige L Williams; Antonia M Calafat; Russ Hauser
Journal:  Reprod Toxicol       Date:  2013-10-04       Impact factor: 3.143

6.  Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey.

Authors:  Mindy S Christianson; Gon Shoham; Kyle J Tobler; Yulian Zhao; Christina N Cordeiro; Milton Leong; Zeev Shoham
Journal:  J Assist Reprod Genet       Date:  2015-09-04       Impact factor: 3.412

7.  The association of protein intake (amount and type) with ovarian antral follicle counts among infertile women: results from the EARTH prospective study cohort.

Authors:  I Souter; Y-H Chiu; M Batsis; M C Afeiche; P L Williams; R Hauser; J E Chavarro
Journal:  BJOG       Date:  2017-04-10       Impact factor: 6.531

8.  Predictive value of anti-Müllerian hormone on pregnancy outcomes in in-vitro fertilization/intracytoplasmic single sperm injection patients at different ages.

Authors:  Yujing Zhang; Liling Wang; Sijia Zhao; Cuilian Zhang; Qiaohua He; Aihua Liao
Journal:  Arch Gynecol Obstet       Date:  2021-05-30       Impact factor: 2.344

9.  Influence of Maternal Age and Ovarian Reserve on the Decision to Continue or to Cancel IVF Cycles in Patients with One or Two Large Follicles: a Dual Effect.

Authors:  Guy Shrem; Mali Salmon-Divon; Alina M Mahfoudh; Jacques Balayla; Alexander Volodarsky-Perel; Sara Henderson; Atif Zeadna; Weon-Young Son; Naama Steiner; Michael H Dahan
Journal:  Reprod Sci       Date:  2021-06-11       Impact factor: 3.060

10.  Comparison of IVF Outcomes between Minimal Stimulation and High-Dose Stimulation for Patients with Poor Ovarian Reserve.

Authors:  Tal Lazer; Shir Dar; Ekaterina Shlush; Basheer S Al Kudmani; Kevin Quach; Agata Sojecki; Karen Glass; Prati Sharma; Ari Baratz; Clifford L Librach
Journal:  Int J Reprod Med       Date:  2014-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.